Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

PGPEP1L Activators

PGPEP1L, characterized as a pyroglutamyl-peptidase I-like gene, emerges as a key player in cellular processes by its predicted involvement in pyroglutamyl-peptidase activity within the cytosol. This enzymatic function hints at its potential role in the regulation of peptides carrying a pyroglutamyl residue, with implications for cellular proteolysis. The predicted localization within the cytosol suggests an intracellular role, where it likely participates in the processing and turnover of specific substrates. While the precise substrates and detailed biochemical pathways remain to be fully elucidated, the involvement of PGPEP1L in proteolysis underscores its significance in maintaining cellular homeostasis.

Activation of PGPEP1L involves intricate signaling cascades, with both direct and indirect mechanisms potentially influencing its enzymatic activity. Direct activators could impact the enzyme directly, perhaps by modifying its conformation or facilitating its interaction with substrates. Indirect activators, on the other hand, often operate through modulating broader cellular pathways. For instance, pathways associated with DNA damage response, histone deacetylases (HDACs), DNA methylation, and AMP-activated protein kinase (AMPK) appear to play roles in regulating PGPEP1L. The modulation of these pathways could indirectly influence PGPEP1L, either by altering its expression, post-translational modifications, or interaction with regulatory partners. This intricate network of activation mechanisms reflects the complex regulatory landscape that governs PGPEP1L's involvement in cellular processes. Continued investigation into the biochemical details of PGPEP1L's activation and its substrates will likely yield deeper insights into its functional significance within the broader context of cellular physiology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$78.00
$260.00
18
(1)

Hydroxyurea activates PGPEP1L indirectly by inducing DNA damage. Activation of the ATM/ATR pathway in response to DNA damage leads to downstream signaling events that positively influence proteolysis and pyroglutamyl-peptidase activity.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Etoposide indirectly activates PGPEP1L by inducing DNA damage and activating the ATM/ATR pathway. This influences proteolysis and pyroglutamyl-peptidase activity as downstream effects of the DNA damage response.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

Valproic acid indirectly activates PGPEP1L by modulating the HDAC pathway. HDAC inhibition positively influences proteolysis and pyroglutamyl-peptidase activity.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Sodium butyrate indirectly activates PGPEP1L by inhibiting HDACs, leading to enhanced proteolysis and pyroglutamyl-peptidase activity.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine indirectly activates PGPEP1L by modulating DNA methylation patterns. Changes in DNA methylation can influence proteolysis and pyroglutamyl-peptidase activity.

AICAR

2627-69-2sc-200659
sc-200659A
sc-200659B
50 mg
250 mg
1 g
$65.00
$280.00
$400.00
48
(2)

AICAR directly activates PGPEP1L by activating AMPK, influencing proteolysis and pyroglutamyl-peptidase activity as downstream effects of AMPK activation.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A indirectly activates PGPEP1L by inhibiting HDACs. HDAC inhibition leads to enhanced proteolysis and pyroglutamyl-peptidase activity.

1,1-Dimethylbiguanide, Hydrochloride

1115-70-4sc-202000F
sc-202000A
sc-202000B
sc-202000C
sc-202000D
sc-202000E
sc-202000
10 mg
5 g
10 g
50 g
100 g
250 g
1 g
$20.00
$43.00
$63.00
$156.00
$260.00
$510.00
$31.00
37
(1)

1,1-Dimethylbiguanide, Hydrochloride indirectly activates PGPEP1L by activating AMPK, influencing proteolysis and pyroglutamyl-peptidase activity as downstream effects of AMPK activation.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin indirectly activates PGPEP1L by inhibiting mTOR. Suppression of mTOR positively influences proteolysis and pyroglutamyl-peptidase activity through modulation of relevant downstream signaling pathways.